Evidence map›Paper›PMID 26076489›Full record

ArticlePloS one2015

Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort.

Alevtina Gall, Jutta Fero, Connor McCoy, Brian C Claywell, Carissa A Sanchez, Patricia L Blount, Xiaohong Li, Thomas L Vaughan, Frederick A Matsen, Brian J Reid and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. The Human Respiratory Microbiome: Current Understandings and Future Directions.American journal of respiratory cell and molecular biology · 2023
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The Human Microbiome-A Physiologic Perspective.Comprehensive Physiology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Alevtina GallMolecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, United States of America; Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Jutta FeroHuman Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Connor McCoyDivisions of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Brian C ClaywellDivisions of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Carissa A SanchezHuman Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Patricia L BlountDivisions of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America.
Xiaohong LiHuman Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Divisions of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Thomas L VaughanDivisions of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Epidemiology, University of Washington, Seattle, Washington, United States of America.
Frederick A MatsenDivisions of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Brian J ReidHuman Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Divisions of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Medicine, University of Washington School of Medicine, Seattle, Washington, United States of America; Department of Genome Sciences, University of Washington, Seattle, Washington, United States of America.
Nina R SalamaHuman Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Microbiology, University of Washington School of Medicine, Seattle, Washington, United States of America.
Fred Hutch Cancer Center · USUniversity of Washington · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian Esvelt · 1985 to 2026
$296.4M
PHYLOGENIES of Barrett's Esophagus LineagesP01CA091955 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI GRADY, WILLIAM MALLORY · 2002 to 2019
$35.9M
University of Washington Medical Scientist Training Program: MD/PhDT32GM007266 · NIGMS · UNIVERSITY OF WASHINGTON · PI HORWITZ, MARSHALL S. · 1985 to 2023
$30.4M
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)R01CA136725 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L, WHITEMAN, DAVID C · 2009 to 2011
$7.8M
INTERDISCIPLINARY PROGRAM IN BACTERIAL PATHOGENESIST32AI055396 · NIAID · UNIVERSITY OF WASHINGTON · PI FANG, FERRIC C · 2003 to 2019
$2.8M
(PQA1) Aspirin and Inflammation: Mutations, Genes, Pathways and PreventionR01CA179949 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LI, XIAOHONG, REID, BRIAN J · 2013 to 2016
$1.9M
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROLK05CA124911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 2007 to 2016
$1.6M
Novel Computational Tools for Studying the Human MicrobiomeR01HG005966 · NHGRI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FREDRICKS, DAVID NEAL, MATSEN, FREDERICK ALBERT · 2010 to 2012
$1.5M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
NCI NIH HHS K05 CA124911NCI NIH HHS P01 CA091955NCI NIH HHS P01 CA 91955NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA136725NCI NIH HHS R01 CA179949NHGRI NIH HHS R01 HG005966NIAID NIH HHS T32 AI055396NIGMS NIH HHS T32 GM007266NIH HHS S10 OD020069
6 · The paper itself

Abstract

backgroundThe incidence of esophageal adenocarcinoma (EAC) has increased nearly five-fold over the last four decades in the United States. Barrett's esophagus, the replacement of the normal squamous epithelial lining with a mucus-secreting columnar epithelium, is the only known precursor to EAC. Like other parts of the gastrointestinal (GI) tract, the esophagus hosts a variety of bacteria and comparisons among published studies suggest bacterial communities in the stomach and esophagus differ. Chronic infection with Helicobacter pylori in the stomach has been inversely associated with development of EAC, but the mechanisms underlying this association remain unclear. METHODOLOGY: The bacterial composition in the upper GI tract was characterized in a subset of participants (n=12) of the Seattle Barrett's Esophagus Research cohort using broad-range 16S PCR and pyrosequencing of biopsy and brush samples collected from squamous esophagus, Barrett's esophagus, stomach corpus and stomach antrum. Three of the individuals were sampled at two separate time points. Prevalence of H. pylori infection and subsequent development of aneuploidy (n=339) and EAC (n=433) was examined in a larger subset of this cohort. RESULTS/SIGNIFICANCE: Within individuals, bacterial communities of the stomach and esophagus showed overlapping community membership. Despite closer proximity, the stomach antrum and corpus communities were less similar than the antrum and esophageal samples. Re-sampling of study participants revealed similar upper GI community membership in two of three cases. In this Barrett's esophagus cohort, Streptococcus and Prevotella species dominate the upper GI and the ratio of these two species is associated with waist-to-hip ratio and hiatal hernia length, two known EAC risk factors in Barrett's esophagus. H. pylori-positive individuals had a significantly decreased incidence of aneuploidy and a non-significant trend toward lower incidence of EAC.

Indexed as

BacteriaGenomic InstabilityMicrobiotaAdenocarcinomaAgedAged, 80 and overBarrett EsophagusBiodiversityDisease SusceptibilityEsophageal NeoplasmsFemaleGastric MucosaHumansIncidenceMaleMetagenome

Identifiers

PMID26076489
PMCPMC4468150
OpenAlexW2106548445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.